Physician Assistant, Medical · Neptune, NJ
NPI
1871543611
Since 2006
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
26 Highway 35 N
Neptune, NJ, 07753
Phone (732) 456-7777
Groups this clinician bills Medicare through
Medicare paid, 2024
$89K
2,863 services
Medicare patients, 2024
520
Average age 70
Drug cost, 2024
$2.2M
3,017 prescriptions
Company payments, 2025
$2,107
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vincent A Polizio was code 17003 (destruction skin lesion), 1,264 times for 135 patients. In total Vincent A Polizio billed 2,863 services in 46 codes, and Medicare paid $89K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,264 | 135 | $4.54 | $5,735 |
| 99213 Office E&M - Established | Office | 446 | 293 | $55.29 | $25K |
| 17000 Destruction Skin Lesion | Office | 263 | 163 | $36.27 | $9,539 |
| 99212 Office E&M - Established | Office | 193 | 137 | $37.03 | $7,147 |
| 11102 Skin Biopsy | Office | 157 | 135 | $60.43 | $9,488 |
| 99203 Office E&M - New | Office | 94 | 94 | $59.17 | $5,562 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 67 | 19 | $0.75 | $50.46 |
| 11103 Skin Biopsy | Office | 62 | 46 | $33.63 | $2,085 |
| 99202 Office E&M - New | Office | 42 | 42 | $40.43 | $1,698 |
| 11900 Skin | Office | 34 | 16 | $35.65 | $1,212 |
| 99214 Office E&M - Established | Office | 33 | 23 | $70.50 | $2,326 |
| 12032 Wound Repair - All Levels | Office | 25 | 22 | $189.68 | $4,742 |
| 17262 Destruction Skin Lesion | Office | 17 | 12 | $103.80 | $1,765 |
| 17110 Destruction Skin Lesion | Office | 15 | 12 | $63.59 | $954 |
| 10060 Skin | Office | 13 | 11 | $58.36 | $759 |
By year: 2022 $87K for 2,508 services; 2023 $76K for 2,348 services; 2024 $89K for 2,863 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vincent A Polizio prescribed most often to Medicare patients was Ketoconazole, with 310 prescriptions and refills. In total Vincent A Polizio wrote 3,017 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 310 | 324 | 81 | $4,885 |
| Clobetasol Propionate Generic | 269 | 275 | 97 | $8,366 |
| Triamcinolone Acetonide Generic | 227 | 241 | 132 | $1,396 |
| Fluocinonide Generic | 179 | 185 | 90 | $6,487 |
| Mometasone Furoate Generic | 156 | 161 | 55 | $2,829 |
| Doxycycline Hyclate Generic | 149 | 149 | 56 | $3,211 |
| Clindamycin Phosphate Generic | 133 | 138 | 39 | $3,747 |
| Hydroxyzine Hcl Generic | 102 | 138 | 30 | $795 |
| Dupixent Pen Dupilumab | 95 | 97 | 11 | $371K |
| Hydrocortisone Generic | 88 | 88 | 34 | $1,302 |
| Metronidazole Generic | 88 | 92 | 29 | $4,821 |
| Ammonium Lactate Generic | 88 | 89 | 32 | $1,427 |
| Ciclopirox Ciclopirox Olamine | 69 | 73 | 35 | $2,332 |
| Betamethasone Dipropionate Generic | 66 | 72 | 23 | $3,450 |
| Minoxidil Generic | 60 | 90 | 14 | $521 |
Brand drugs: - claims; generic drugs: 2,610 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vincent A Polizio $2,107 ($2,107 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $511.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 47 | $511 |
| UCB, Inc. UCB.BR | 39 | $397 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $380 |
| Regeneron Healthcare Solutions, Inc. REGN | 18 | $174 |
| Pfizer Inc. PFE | 18 | $162 |
| Incyte Corporation INCY | 11 | $142 |
| Amgen Inc. AMGN | 9 | $139 |
| Lilly USA, LLC LLY | 3 | $50.08 |
| Janssen Biotech, Inc. JNJ | 3 | $43 |
| Organon LLC OGN | 2 | $29.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.